|
News For FRX;IRWD From The Last 14 Days Check below for free stories on FRX;IRWD the last two weeks. |
|
|
| May 24, 2013 |
| 09:41 EDT |  | IRWD | Ironwood has a conference call hosted by JPMorgan
JPMorgan Analyst Meacham will host a conference call with CEO Peter Hecht on May 24 at 10 am. |
|
| May 23, 2013 |
| 08:10 EDT |  | FRX | Forest Labs says Howard Solomon to retire as CEO, President at year end
Forest Laboratories announced that Howard Solomon will retire as Chief Executive Officer and President, effective December 31, 2013. Subject to the same nominating and election processes annually as all directors, Solomon is expected to remain as Chairman through the 2014 Annual General Meeting, at which time another Chairman will be elected. Solomon will retain the title of Chairman Emeritus after the 2014 AGM and has agreed to serve as Senior Advisor to the Company following his retirement as CEO and President. As previously disclosed, an independent committee of Forest’s Board has been engaged in a succession planning process, including evaluating internal and external candidates. With Solomon’s retirement announcement, the Board has determined to bring the process to a close and expects to name a successor before the end of the year. The committee is being assisted by executive search firm Spencer Stuart, the company said. |
|
| 08:04 EDT | | FRX | Forest Labs says Howard Solomon to retire as CEO, President at year end
 Subscribe for More Information |
|
| May 22, 2013 |
| 06:47 EDT |  | IRWD | Ironwood likely to raise money again in early 2014, says Cantor
Cantor believes Ironwood's 10.5M share offering provides the company with adequate cash for another three-to-four quarters of operations. However, Cantor thinks Ironwood will need to raise money again in early 2014 and reiterates a Sell rating on the stock with a $9 price target. |
|
| May 21, 2013 |
| 18:30 EDT |  | IRWD | Ironwood 10.5M share Secondary priced at $13.00
JPMorgan, BofA/Merrill and Morgan Stanley acted as joint book running managers for the offering. |
|
| May 20, 2013 |
| 16:05 EDT | | IRWD | Ironwood files to sell 10.5M shares of common stock
J.P. Morgan and BofA Merrill Lynch are acting as joint bookrunning managers and as representatives of the underwriters for the offering. Morgan Stanley is acting as bookrunning manager for the offering. |
|
| 07:28 EDT | | FRX | American Thoracic Society to hold a conference
Subscribe for More Information |
|
| 07:27 EDT | | FRX | American Psychiatric Association to host annual meeting
Subscribe for More Information |
|
| 07:11 EDT | | IRWD | Ironwood Linzess may not be suitable for some patients, says Cantor
After analyzing clinical data, Cantor believes that doctors will stop prescribing Ironwood's Linzess to patients who are not getting relief from constipation from the drug initially, while other patients will stop using the drug after two to three months. After attending two events connected with the launch of the drug, the firm thinks interest in it is disappointing, and it reiterates a Sell rating on the stock. |
|
| May 17, 2013 |
| 10:36 EDT | | IRWD, FRX | Leerink's major/specialty pharma analyst holds analyst/Industry conference call
Subscribe for More Information |
| |
| May 15, 2013 |
| 11:37 EDT |  | IRWD | High option volume stocks: CONN IRWD JASO LYV CSC
|
|
|
|
|
|
